IMDX Competitors & Alternatives

Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry

Diagnostics & Research

IMDX

Main Stock
$1.66
+4.40%
Tradestie Score
48
Market Cap
$94.16M
Revenue Growth
115.0%
Analyst Upside
+336.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other Molecular Diagnostics
Competitive Moat: None
Core Technology Stack: NGS, PCR, Variant analysis
Major Customers 3
Clinical labs Hospitals Oncology centers
Critical Suppliers 2
Reagent providers Sequencing platform vendors
Direct Ecosystem Rivals 3

Top Competitors

40 stocks in Diagnostics & Research
Company Price Market Cap P/E Score Action
CDNA CareDx, Inc.
$71.92
-3.39%
$798.40M 31.5 39 Compare
FLGT Fulgent Genetics, Inc. Common Stock
$24.78
-1.39%
$719.31M - 30 Compare
MYGN Myriad Genetics Inc
$5.54
+0.18%
$719.23M - 47 Compare
CSTL Castle Biosciences, Inc. Common Stock
$33.41
+0.07%
$667.77M - 65 Compare
PSNL Personalis, Inc. Common Stock
$14.72
-1.74%
$612.76M - 56 Compare
LCTX Lineage Cell Therapeutics, Inc.
$0.82
-2.21%
$385.92M - 57 Compare
VTVT vTv Therapeutics Inc. Class A Common Stock
$16.36
+0.80%
$62.81M - 37 Compare
AKTX Akari Therapeutics plc ADR (0.01 USD)
$6.71
+0.90%
$31.97M - 54 Compare
SYBX Synlogic, Inc. Common Stock
$0.56
-50.00%
$19.89M - 42 Compare
XBIO Xenetic Biosciences, Inc.
$1.54
+0.65%
$4.78M - 52 Compare

Data updated: Nov 19, 2026 | Industry: Diagnostics & Research (SIC 2835)

40 stocks in this industry